News | March 13, 2013

First Commercial Installation of GE’s Optima NM/CT 640 System Announced

Texas Health Harris Methodist Hospital Fort Worth adds imaging capabilities with high-precision, low radiation dose SPECT/CT technology

March 13, 2013 — GE Healthcare announced last month the first global commercial installation of its Optima NM/CT 640 technology, a new performance SPECT/CT (single-photon emission computed tomography/computed tomography) system that helps physicians balance high image quality with low patient radiation dose and efficiency. The installation is at Texas Health Harris Methodist Hospital Fort Worth in Fort Worth, Texas.

The Optima NM/CT 640 enables clinicians to focus on key needs in diagnostic imaging, including high-quality visuals, low radiation dose and short exam times for patients. The Optima NM/CT 640 allows for hybrid imaging rather than standalone CT use, integrating the latest generation general purpose camera with a newly developed four-slice CT. Available in 2.5 mm and 5 mm slice thicknesses, the CT technology is designed to optimize dose and resolution required for particular procedures, offering clinicians high-quality images with routinely low CT dose at 1-2 mSv for a 40 cm abdomen CT scan.

The Optima NM/CT 640 requires minimal renovation and installation costs and can be fully upgraded for future use, expanding its clinical applications as well as offering the potential for research capabilities. When used with the Xeleris workstation, Optima NM/CT allows clinicians to potentially reduce time or injected patient dose by up to 50 percent in most scanning procedures while maintaining image quality.

“We are dedicated to pushing nuclear medicine to its full potential and developing equipment that helps customers address the challenges they are confronted with every day — high image quality, low dose and short exam times,” said Nathan Hermony, general manager, nuclear medicine, GE Healthcare. “We are pleased to collaborate with clinical leaders at Texas Health Harris Methodist Hospital Fort Worth on the first global installation of Optima NM/CT 640 technology as they continue to deliver diagnostic excellence and quality patient care.”

Texas Health Fort Worth is a 726-bed, Magnet-designated regional referral center with more than 4,000 employees, 200 volunteers and nearly 1,000 physicians practicing on the medical staff. The hospital’s services include cardiovascular services, high-risk and routine obstetrics and gynecology, orthopedics and sports medicine, neonatal intensive care, and trauma/emergency medicine. Texas Health Fort Worth is an affiliate of the faith-based, nonprofit Texas Health Resources system.

For more information: www.gehealthcare.com

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Overlay Init